cancer vaccine
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
cancer vaccine
Jun 22, 2024, 03:59 |
Insight
Shahrin Ahmed: The results of a melanoma jab trial were extremely impressive
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: “The results of a…
Jun 8, 2024, 06:52 |
Blog
Gabriela Burgos: My key takeaways from ASCO 2024
Gabriela Burgos, Associate Research Director- Evidence Generation Lead, RWE at Oracle shared a post on LinkedIn:…
Jun 1, 2024, 12:50 |
Blog
Lennard YW Lee: We are now one of the leading cancer research infrastructure for personalised cancer vaccine trials
Lennard YW Lee, Associate Professor at the University of Oxford, shared on LinkedIn: "Feeling proud…
May 1, 2024, 11:59 |
Opinion
Bernard A. Fox: Dark Matter is the biggest breakthrough in cancer immunotherapy of the last 3 years
Bernard A. Fox, Co-Founder and CEO of UbiVac shared on LinkedIn: “Best response rate for recurrent…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube